1150262-33-1

Basic information

• Product Name: benzyl [(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]carbamate
• Synonyms: benzyl [(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]carbamate
• CAS NO: 1150262-33-1
• Molecular Weight: 261.28
• Mol File: 1150262-33-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: benzyl [(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl [(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]carbamate(1150262-33-1)
• EPA Substance Registry System: benzyl [(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]carbamate(1150262-33-1)

Safety Data

• Hazardous Substances Data: 1150262-33-1(Hazardous Substances Data)

Upstream product

• 2466-76-4 N-Acetylimidazole 
• 1150566-62-3 benzyl [(1R,2Z)-2-amino-2-(hydroxyimino)-1-methylethyl]carbamate 
• 151378-81-3 benzyl [(1R)-2-amino-1-methyl-2-oxoethyl]carbamate 
• 176894-58-9 (2R)-2-(benzyloxycarbonylamino)propionitrile 

Relevant articles and documents

P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN

The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor s

P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN

The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.